Snapshot: Bain talks QuVa expansion

Bain Capital principal Jeff Schwartz tells Private Equity International that the firm’s decision to build the QuVa Pharma platform that manufactures sterile pharmaceutical products for hospitals, was a response to changes to FDA regulation.